Edited News Release:
Gastric ulceration is a widespread clinical finding among performance horses in training as well as in foals. Prevalence of up to 93% has been documented among horses in race training1 and in nearly 60% of other performance horses.
The disease complex that precipitates ulceration of the esophageal, gastric, or duodenal mucosa in the horse is referred to as Equine Gastric Ulcer Syndrome (EGUS). It includes both asymptomatic and symptomatic cases; focal or multifocal ulceration of squamous mucosa, glandular mucosa, or both; and gastritis and complications of these disorders.
EGUS ranges from mild erosion to craters that penetrate the mucosa with a spectrum of severity, ranging from inflamed but intact epithelium to single, superficial erosions of the mucosal surface, and from there to multiple actively hemorrhaging hyperemic and/or necrotic craters extending beneath the mucosal surface. In severe cases, perforation may occur, and when it does, it is usually fatal.
GASTROGARD® (omeprazole) is the only ulcer medication which is FDA-approved to treat equine stomach ulcers.
About the author
As an animal lover since childhood, Flossie was delighted when Mark, the CEO and developer of EquiMed asked her to join his team of contributors.
She enrolled in My Horse University at Michigan State and completed a number of courses in everything related to horse health, nutrition, diseases and conditions, medications, hoof and dental care, barn safety, and first aid.
Staying up-to-date on the latest developments in horse care and equine health is now a habit, and she enjoys sharing a wealth of information with horse owners everywhere..